Bolt Biotherapeutics Inc
NASDAQ:BOLT

Watchlist Manager
Bolt Biotherapeutics Inc Logo
Bolt Biotherapeutics Inc
NASDAQ:BOLT
Watchlist
Price: 5.6 USD -3.28%
Market Cap: 10.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+42%
Revenue
Forecast
+11%
Operating Income
Forecast
+62%
Net Income
Forecast
+86%

Wall Street
Price Targets

BOLT Price Targets Summary
Bolt Biotherapeutics Inc

Wall Street analysts forecast BOLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOLT is 40.8 USD with a low forecast of 20.2 USD and a high forecast of 84 USD.

BOLT Lowest Forecast
Wall Street Target
20.2 USD
261% Upside
BOLT Average Forecast
Wall Street Target
40.8 USD
629% Upside
BOLT Highest Forecast
Wall Street Target
84 USD
1 400% Upside
Lowest
Price Target
20.2 USD
261% Upside
Average
Price Target
40.8 USD
629% Upside
Highest
Price Target
84 USD
1 400% Upside
Bolt Biotherapeutics Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
34% Downside
KNSA
Kiniksa Pharmaceuticals Ltd
29% Upside
KMDA
Kamada Ltd
87% Upside
VRTX
Vertex Pharmaceuticals Inc
16% Upside
2616
CStone Pharmaceuticals
34% Downside
KNSA
Kiniksa Pharmaceuticals Ltd
29% Upside
KMDA
Kamada Ltd
87% Upside
VRTX
Vertex Pharmaceuticals Inc
16% Upside
CVAC
CureVac NV
2% Downside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
7% Downside
DBV
DBV Technologies SA
164% Upside
GLPG
Galapagos NV
29% Upside

Revenue
Forecast

Revenue Estimate
Bolt Biotherapeutics Inc

For the last 5 years the compound annual growth rate for Bolt Biotherapeutics Inc's revenue is 104%. The projected CAGR for the next 3 years is 35%.

104%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bolt Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bolt Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

See Also

Summary
BOLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
BOLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BOLT stock valuation using valuation multiples.
Wall Street Estimates
BOLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BOLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOLT's stock price target?
Price Target
40.8 USD

According to Wall Street analysts, the average 1-year price target for BOLT is 40.8 USD with a low forecast of 20.2 USD and a high forecast of 84 USD.

What is Bolt Biotherapeutics Inc's Revenue forecast?
Projected CAGR
35%

For the last 5 years the compound annual growth rate for Bolt Biotherapeutics Inc's revenue is 104%. The projected CAGR for the next 3 years is 35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.